Authors:
Goh, BC
Lehnert, M
Lim, HL
Ng, AWK
Chan, CC
Kong, HL
Lee, SC
Wee, J
Chua, ET
Wong, JEL
Citation: Bc. Goh et al., Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer, ACTA ONCOL, 39(2), 2000, pp. 225-229
Authors:
Tan, EH
Khoo, KS
Wee, J
Fong, KW
Lee, KS
Lee, KM
Chua, ET
Tan, T
Khoo-Tan, HS
Yang, TL
Au, E
Tao, M
Ong, YK
Chua, EJ
Citation: Eh. Tan et al., Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma, ANN ONCOL, 10(2), 1999, pp. 235-237
Authors:
Tan, EH
Chua, ET
Wee, J
Tan, T
Fong, KW
Ang, PT
Lee, KS
Lee, KM
Khoo-Tan, HS
Leong, SS
Ong, YK
Foo, KF
Sethi, VK
Chua, EJ
Citation: Eh. Tan et al., Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: Toxicities and preliminary results, INT J RAD O, 45(3), 1999, pp. 597-601
Authors:
Heng, DMK
Wee, J
Fong, KW
Lian, LG
Sethi, VK
Chua, ET
Yang, TL
Tan, HSK
Lee, KS
Lee, KM
Tan, T
Chua, EJ
Citation: Dmk. Heng et al., Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma, CANCER, 86(10), 1999, pp. 1912-1920